| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000023342 |
| Receipt No. | R000022978 |
| Official scientific title of the study | Genetic counseling for medical genetics using next-generation sequencing in children's hospital |
| Date of disclosure of the study information | 2016/07/27 |
| Last modified on | 2016/07/26 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Genetic counseling for medical genetics using next-generation sequencing in children's hospital | |
| Title of the study (Brief title) | Genetic counseling for medical genetics using next-generation sequencing in children's hospital | |
| Region |
|
|
| Condition | ||
| Condition | multiple congenital anomalies/developmental delay or intellectual disability | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To determine the information needs in genetic counseling, regarding next-generation DNA sequencing (NGS) |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To assess the level of understanding of patient's parents for testing strategy using NGS |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The parents of patients undergoing the genetic testings using NGS. | |||
| Key exclusion criteria | The parents of patients of rejecting the agreement for the genetic testings using NGS. | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Yoshihashi |
| Organization | Tokyo Metropolitan Children's Medical Hospital |
| Division name | Department of Medical Genetics |
| Address | 2-8-29 Musashidai Fuchu, Tokyo |
| TEL | 042-300-5111 |
| hiroshi_yoshihasi@tmhp.jp | |
| Public contact | |
| Name of contact person | Hiroshi Yoshihashi |
| Organization | Tokyo Metropolitan Children's Medical Hospital |
| Division name | Department of Medical Genetics |
| Address | 2-8-29 Musashidai Fuchu, Tokyo |
| TEL | 042-300-5111 |
| Homepage URL | |
| hiroshi_yoshihasi@tmhp.jp | |
| Sponsor | |
| Institute | Tokyo Metropolitan Children's Medical Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Tokyo Metropolitan Children's Medical Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | No other information |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022978 |